Roflumilast restores cAMP/PKA/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancerShipeng Gong(Nanfang Hospital), Fei Wu(Nanfang Hospital)OncotargetDecember 2, 201710.18632/oncotarget.22866Cited by 45SaveCiteExport RISWatch citationsRelated PapersRoflumilast enhances cisplatin‐sensitivity and reverses cisplatin‐resistance of ovarian cancer cells via <scp>cAMP</scp>/<scp>PKA</scp>/<scp>CREB</scp>‐FtMt signalling axis|Cell Proliferation|2018|28MyoD1 promotes the transcription of BIK and plays an apoptosis-promoting role in the development of gastric cancer|Cell Cycle|2024|6